Public Employees Retirement Association of Colorado reduced its stake in Aetna Inc. (NYSE:AET) by 5.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 73,366 shares of the company’s stock after selling 3,884 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Aetna were worth $8,960,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Wexford Capital LP bought a new stake in Aetna during the first quarter valued at approximately $494,000. Credit Agricole S A raised its stake in Aetna by 131.4% in the first quarter. Credit Agricole S A now owns 503,383 shares of the company’s stock valued at $56,556,000 after buying an additional 285,873 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in Aetna by 12.3% in the first quarter. Canada Pension Plan Investment Board now owns 268,304 shares of the company’s stock valued at $30,144,000 after buying an additional 29,300 shares in the last quarter. Pegasus Partners Ltd. bought a new stake in Aetna during the first quarter valued at approximately $645,000. Finally, Lazard Asset Management LLC raised its stake in Aetna by 40.5% in the first quarter. Lazard Asset Management LLC now owns 2,373,143 shares of the company’s stock valued at $266,622,000 after buying an additional 684,597 shares in the last quarter. Institutional investors and hedge funds own 91.95% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded down 0.13% during mid-day trading on Friday, hitting $109.64. The company had a trading volume of 2,294,180 shares. Aetna Inc. has a 12 month low of $92.42 and a 12 month high of $123.57. The company has a market cap of $38.46 billion, a PE ratio of 16.07 and a beta of 0.54. The firm has a 50-day moving average of $114.96 and a 200-day moving average of $115.74.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, August 2nd. The company reported $2.21 EPS for the quarter, topping the Zacks’ consensus estimate of $2.12 by $0.09. The company had revenue of $15.95 billion for the quarter, compared to the consensus estimate of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. Aetna’s quarterly revenue was up 4.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.05 earnings per share. On average, analysts expect that Aetna Inc. will post $8.05 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.00 annualized dividend and a yield of 0.91%. Aetna’s dividend payout ratio (DPR) is presently 14.73%.
AET has been the topic of several recent research reports. Leerink Swann restated an “outperform” rating on shares of Aetna in a research report on Tuesday, June 21st. Wolfe Research started coverage on Aetna in a research report on Tuesday, June 28th. They set an “outperform” rating and a $154.00 target price on the stock. Credit Suisse Group AG reiterated a “hold” rating and set a $120.00 target price on shares of Aetna in a research report on Wednesday, June 29th. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $133.00 target price on the stock in a research report on Tuesday, July 19th. Finally, FBR & Co reiterated a “hold” rating and set a $135.00 target price on shares of Aetna in a research report on Thursday, August 4th. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Aetna has an average rating of “Buy” and an average target price of $132.43.
In related news, Director Jeffrey E. Garten sold 7,100 shares of the stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Shawn M. Guertin sold 45,328 shares of the stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total value of $5,448,878.88. Following the transaction, the insider now owns 44,883 shares in the company, valued at $5,395,385.43. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.